ArticleEuropean journal of medical research2025
Dihydromyricetin alleviates attention deficit hyperactivity disorder by modulating the SIRT1/Nrf2/Keap1/HO-1 signaling pathway.
Huanhuan Zang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.